SCHEMBL18166715

SCHEMBL18166715

Cn1c(=O)c2c(ncn2CC(=O)Nc2nnc(-c3ccc(F)cc3)s2)n(C)c1=O

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.67
▸ RXFP1 Q9HBX9 4/20 0.65
▸ PORCN Q9H237 3/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ MAPT P10636 2/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ HTT P42858 1/20 0.61
▸ CYP1A2 P05177 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ TP53 P04637 1/20 0.55
▸ TRPA1 O75762 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ THRB P10828 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166637 0.91 HSD17B10 (0.67) HSD17B10RXFP1PORCNALDH1A1MAPT
SCHEMBL18166765 0.90 HSD17B10 (0.78) HSD17B10RXFP1PORCNALDH1A1CYP2C9
SCHEMBL18166657 0.83 MAPT (0.82) RXFP1PORCNMAPTCYP1A2ALOX15
SCHEMBL3826453 0.83 TRPA1 (0.77) RXFP1PORCNCYP1A2ALOX15TP53
SCHEMBL17626504 0.82 PORCN (0.63) RXFP1PORCNMAPTCYP1A2ALOX15
SCHEMBL17200781 0.82 RXFP1 (0.68) HSD17B10RXFP1PORCNALDH1A1MAPT
SCHEMBL17628692 0.81 PORCN (0.82) RXFP1PORCNALDH1A1MAPTCYP1A2
SCHEMBL15727746 0.81 HSD17B10 (0.75) HSD17B10RXFP1ALDH1A1CYP2C9HPGD
SCHEMBL10113976 0.79 LMNA (0.70) RXFP1CYP1A2ALOX15TP53TSHR
SCHEMBL10113960 0.79 HSD17B10 (0.72) HSD17B10RXFP1ALDH1A1CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
CN-101801362-B Methods and compositions for treating disorders HYDRA BIOSCIENCES INC 2014-01-22 — — CN disclosed
CN-101801362-A methods and compositions for treating disorders HYDRA BIOSCIENCES INC 2010-08-11 — — CN disclosed
Send feedback